FHA
BEAT

Flagship Harbor Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Flagship Harbor Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4
Closed – – 2012
2019
Q3 		$0 Hold
4
– – ﹤0.01% 2047
2019
Q2 		$0 Hold
4
– – ﹤0.01% 2043
2019
Q1 		$0 Hold
4
– – ﹤0.01% 2028
2018
Q4 		$0 Hold
4
– – ﹤0.01% 2229
2018
Q3 		$0 Buy
+4
New +$223 ﹤0.01% 2194

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Flagship Harbor Advisors's BEAT Position: Q4 2019 in Review

Flagship Harbor Advisors sold out of BioTelemetry, Inc. (BEAT) in Q4 2019, closing a stake of 4 shares.

Flagship Harbor Advisors first reported a position in BEAT in Q3 2018 and held it in 5 quarters. The position peaked at $0 in Q3 2019. 219 funds tracked by Wall St. Rank hold BEAT as of Q4 2019.

  • Flagship Harbor Advisors reported no remaining BioTelemetry, Inc. position as of Q4 2019 after selling out during the quarter.
  • Flagship Harbor Advisors sold 4 BioTelemetry, Inc. shares in Q4 2019.
  • Flagship Harbor Advisors first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 5 quarters.
  • Flagship Harbor Advisors's BioTelemetry, Inc. position peaked at $0 in Q3 2019.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2019.

Based on Flagship Harbor Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.